Bibliografía:
Plotkin, S.A., Mortimer, E. Vaccines. New York: Harper Perennial; 1988.
Plotkin, S.A., Orenstein, W.A., Offit, P.A., eds. Vaccines, 6th ed. Philadelphia: Elsevier; 2013
.T. Schlake, A. Thess, M. Fotin-Mleczek, y K.-J. Kallen, «Developing mRNA-vaccine technologies», RNA Biol., vol. 9, n.o 11, pp. 1319-1330, nov. 2012, doi: 10.4161/rna.22269.
N. Pardi, M. J. Hogan, F. W. Porter, y D. Weissman, «mRNA vaccines — a new era in vaccinology», Nat. Rev. Drug Discov., vol. 17, n.o 4, pp. 261-279, abr. 2018, doi: 10.1038/nrd.2017.243.
Y. Dong, T. Dai, Y. Wei, L. Zhang, M. Zheng, y F. Zhou, «A systematic review of SARS-CoV-2 vaccine candidates», Signal Transduct. Target. Ther., vol. 5, n.o 1, p. 237, dic. 2020, doi: 10.1038/s41392-020-00352-y.
K. Rawat, P. Kumari, y L. Saha, «COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies», Eur. J. Pharmacol., vol. 892, p. 173751, feb. 2021, doi: 10.1016/j.ejphar.2020.173751.
S. P. Kaur y V. Gupta, «COVID-19 Vaccine: A comprehensive status report», Virus Res., vol. 288, p. 198114, oct. 2020, doi: 10.1016/j.virusres.2020.198114.